rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Yajing Chen

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Zai Lab.

In numbers

Trades disclosed
100
Buys
0
Sells
21
Bought
$0
Sold
$1.3M
Companies
1
Companies where not an officer
0
First trade
14 Aug 2023
Last trade
1 Oct 2026
Last filed
5 Oct 2026

Companies traded

Where they are an officer
ZLAB Zai LabOfficer · Biotechnology · last 1 Oct 20260 buys · 21 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Oct 2026filed 5 Oct 2026ZLAB Zai LabBiotechnologySEC FORM 4 Code M—920filing
1 Oct 2026filed 5 Oct 2026ZLAB Zai LabBiotechnologySEC FORM 4 Code F$8,033315 at $25.50filing
1 Oct 2026filed 5 Oct 2026ZLAB Zai Laboption or derivative · BiotechnologySEC FORM 4 Code M—920 at $0.00filing
19 Aug 2026filed 21 Aug 2026ZLAB Zai LabBiotechnologySEC FORM 4 Sold$7,020260 at $27.00filing
19 Aug 2026filed 21 Aug 2026ZLAB Zai LabBiotechnologySEC FORM 4 Sold$7,020260 at $27.00filing
14 Aug 2026filed 18 Aug 2026ZLAB Zai LabBiotechnologySEC FORM 4 Code M—1,250filing
14 Aug 2026filed 18 Aug 2026ZLAB Zai LabBiotechnologySEC FORM 4 Code F$11K427 at $25.90filing
14 Aug 2026filed 18 Aug 2026ZLAB Zai Laboption or derivative · BiotechnologySEC FORM 4 Code M—1,250 at $0.00filing
14 Aug 2026filed 18 Aug 2026ZLAB Zai Laboption or derivative · BiotechnologySEC FORM 4 Code M—1,250 at $0.00filing
14 Aug 2026filed 18 Aug 2026ZLAB Zai LabBiotechnologySEC FORM 4 Code M—1,250filing
14 Aug 2026filed 18 Aug 2026ZLAB Zai LabBiotechnologySEC FORM 4 Code F$11K427 at $25.90filing
11 Aug 2026filed 13 Aug 2026ZLAB Zai LabBiotechnologySEC FORM 4 Sold$15K619 at $25.00filing
11 Aug 2026filed 13 Aug 2026ZLAB Zai LabBiotechnologySEC FORM 4 Sold$15K619 at $25.00filing
26 Jun 2026filed 29 Jun 2026ZLAB Zai LabBiotechnologySEC FORM 4 Sold$40K2,264 at $17.46filing
26 Jun 2026filed 29 Jun 2026ZLAB Zai LabBiotechnologySEC FORM 4 Sold$40K2,264 at $17.46filing
25 Jun 2026filed 29 Jun 2026ZLAB Zai LabBiotechnologySEC FORM 4 Code M—6,250filing
25 Jun 2026filed 29 Jun 2026ZLAB Zai Laboption or derivative · BiotechnologySEC FORM 4 Code M—6,250 at $0.00filing
25 Jun 2026filed 29 Jun 2026ZLAB Zai Laboption or derivative · BiotechnologySEC FORM 4 Code M—6,250 at $0.00filing
25 Jun 2026filed 29 Jun 2026ZLAB Zai LabBiotechnologySEC FORM 4 Code M—6,250filing
6 Apr 2026filed 8 Apr 2026ZLAB Zai LabBiotechnologySEC FORM 4 Sold$17K853 at $20.45filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care21

Buys in green, sells in red, by the company’s sector.

Related people

William LisDirector · Director at Zai Lab, filing Form 4 there in the last year
Richard GaynorDirector · Director at Zai Lab, filing Form 4 there in the last year
Ying DuChairperson & CEO · Chairperson & CEO at Zai Lab, filing Form 4 there in the last year
Frazor Titus Edmondson IIIChief Legal Officer · Chief Legal Officer at Zai Lab, filing Form 4 there in the last year
Michel VounatsosDirector · Director at Zai Lab, filing Form 4 there in the last year